Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II Study

Background: Extension of dual antiplatelet therapy (DAPT) beyond 1 year after acute coronary syndrome is associated with a reduction in ischemic events but also increased bleeding. The DAPT score identifies individuals likely to derive overall benefit or harm from DAPT extension. We sought to evalua...

Descrición completa

Detalles Bibliográficos

Principais autores:	Yaron Arbel, MD, Ashish D. Patel, MD, Shaun G. Goodman, MD, MSc, Mary K. Tan, MSc, Neville Suskin, MBChB, MSc, Robert S. McKelvie, MD, PhD, Andrew L. Mathew, MD, Firas Ahmed, MD, Sohrab Lutchmedial, MDCM, Payam Dehghani, MD, Andrea J. Lavoie, MD, Thao Huynh, MD, MSc, PhD, Shahar Lavi, MD, Razi Khan, MD, Andrew T. Yan, MD, Christopher B. Fordyce, MD, MHS, MSc, Michael Heffernan, MD, PhD, Sean Jedrzkiewicz, MD, Mina Madan, MD, MHS, Shaheeda Ahmed, MD, Colin Barry, MD, Jean-Pierre Dery, MD, Akshay Bagai, MD, MHS
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2021-12-01
Series:	CJC Open
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2589790X21001980
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!